Status:

COMPLETED

PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions

Lead Sponsor:

Ruijin Hospital

Collaborating Sponsors:

Shanghai Pulmonary Hospital, Shanghai, China

Jiangsu Province Hospital of Traditional Chinese Medicine

Conditions:

Lung Cancers

Pulmonary Lymphomas

Eligibility:

All Genders

18+ years

Brief Summary

First, we analyse the types, imaging findings and relevant treatment responses based on PET/CT to complete a more comprehensive view of pulmonary lymphomas. Then, some models based on radiomics featu...

Detailed Description

1. The local image feature extraction software (LIFEx, v 7.4.0, France) was employed for the image review and measurement of relevant data. Three observers independently interpreted the images. In cas...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Adult patients (≥18 years);
  • Primary or recurrent lymphoma, ≥6 months from last treatment; primary lung cancer patients without prior malignancy;
  • Benign solid lung lesions, without prior malignancy;
  • Pulmonary metastasis, untreated with lung radiotherapy or particle implantation;
  • Baseline assessment revealing PET-positive pulmonary lesions.
  • Pathological results within 3 months of exam date, confirmed lung lesion types via tracheoscopy, lung puncture, or surgery.
  • Baseline pulmonary lesions remaining considered to be pulmonary lymphoma (or metastases) based on follow-up clinical and imaging evaluation.
  • Exclusion criteria:
  • Poor image quality;
  • Inability to delineate the boundaries of lung lesions on CT images;
  • Artifacts caused by nearby devices such as stents or drainage tubes.

Exclusion

    Key Trial Info

    Start Date :

    April 1 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    April 30 2025

    Estimated Enrollment :

    647 Patients enrolled

    Trial Details

    Trial ID

    NCT06602674

    Start Date

    April 1 2024

    End Date

    April 30 2025

    Last Update

    July 23 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine

    Shanghai, Shanghai Municipality, China, 200025